Register: click here!

Effective February 19, 2026, New York State law permits clinicians to administer or dispense up to 72 hours of methadone or buprenorphine for the management of opioid withdrawal while arranging referral and linkage to care for persons with opioid use disorder, as authorized by federal regulations. This update - informally known as the “72-Hour Rule” - will impact clinicians across the state. Join our panel of experts to learn what you need to know about the updated law and its implementation.